Bodisen Biotech (LSE:BODI) Asset Impairment Charge : £0.00 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Asset Impairment Charge?

Bodisen Biotech's Asset Impairment Charge for the three months ended in Jun. 2013 was £0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2013 was £0.00 Mil.

Bodisen Biotech Asset Impairment Charge Historical Data

The historical data trend for Bodisen Biotech's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Asset Impairment Charge Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Asset Impairment Charge

Get a 7-Day Free Trial

1.76

7.32

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Bodisen Biotech Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00 Mil.

Bodisen Biotech Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.